What are Metabolic support therapy drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Metabolic support therapy drugs are pharmacologic agents that share a common mechanism. 0 are currently marketed, with 1 more in clinical development.

Metabolic support therapy

0 marketed 1 in Phase 3

This page covers all Metabolic support therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Phase 3 pipeline (1)

Glucose-Insulin-Potassium · Centre Hospitalier Universitaire Vaudois · Cardiovascular
Glucose-Insulin-Potassium (GIK) therapy delivers glucose, insulin, and potassium together to improve myocardial metabolism and reduce ischemic injury during acute cardiac events.

Patent intelligence

metabolic support therapy patent landscape — aggregated cliff calendar, attackable patents, originator estates